Part D plans ramp up prior authorization

(By Rylee Wilson for Becker’s Hospital Review)

Medicare Part D plans have ramped up restrictions on prescription drugs since 2011, a study published in the March edition of Health Affairs found.

In 2011, Part D plans excluded 20.4% of compounds from formularies and subjected 11.5% to prior authorization or step therapy. In 2020, plans excluded 30.4% of compounds and placed 14% under prior authorization or step therapy. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.